257 related articles for article (PubMed ID: 16200457)
1. The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma.
Brown P; Marafioti T; Kusec R; Banham AH
J Mol Histol; 2005 May; 36(4):249-56. PubMed ID: 16200457
[TBL] [Abstract][Full Text] [Related]
2. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
[TBL] [Abstract][Full Text] [Related]
4. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
5. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
[TBL] [Abstract][Full Text] [Related]
6. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
7. Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays.
McCune RC; Syrbu SI; Vasef MA
Mod Pathol; 2006 Jul; 19(7):1010-8. PubMed ID: 16648862
[TBL] [Abstract][Full Text] [Related]
8. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
9. Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell.
Marafioti T; Hummel M; Anagnostopoulos I; Foss HD; Huhn D; Stein H
J Clin Oncol; 1999 Dec; 17(12):3804-9. PubMed ID: 10577852
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 oncoprotein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B-cell proliferations is of diagnostic value.
Wang T; Lasota J; Hanau CA; Miettinen M
APMIS; 1995 Sep; 103(9):655-62. PubMed ID: 7488387
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers.
Nam-Cha SH; Montes-Moreno S; Salcedo MT; Sanjuan J; Garcia JF; Piris MA
Mod Pathol; 2009 Aug; 22(8):1006-15. PubMed ID: 19465900
[TBL] [Abstract][Full Text] [Related]
12. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
13. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
[TBL] [Abstract][Full Text] [Related]
14. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
15. Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma.
García-Cosío M; Santón A; Martín P; Camarasa N; Montalbán C; García JF; Bellas C
Mod Pathol; 2004 Dec; 17(12):1531-8. PubMed ID: 15257313
[TBL] [Abstract][Full Text] [Related]
16. FOXP1 molecular cytogenetics and protein expression analyses in primary cutaneous large B cell lymphoma, leg-type.
Espinet B; García-Herrera A; Gallardo F; Baró C; Salgado R; Servitje O; Estrach T; Colomo L; Romagosa V; Barranco C; Serrano S; Campo E; Pujol RM; Solé F
Histol Histopathol; 2011 Feb; 26(2):213-21. PubMed ID: 21154235
[TBL] [Abstract][Full Text] [Related]
17. T-cell rich b-cell non-hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance hodgkin's disease.
De Jong D; Van Gorp J; Sie-Go D; Van Heerde P
Histopathology; 1996 Jan; 28(1):15-24. PubMed ID: 8838116
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I is expressed in classical and nodular lymphocyte-predominant Hodgkin's lymphoma tumour and microenvironmental cells.
Eppler E; Janas E; Link K; Weidmann L; Bischofberger H; Wenger M; Tinguely M; Schraml P; Moch H; Fellbaum C
Cell Tissue Res; 2015 Mar; 359(3):841-51. PubMed ID: 25487403
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.
Marafioti T; Mancini C; Ascani S; Sabattini E; Zinzani PL; Pozzobon M; Pulford K; Falini B; Jaffe ES; Müller-Hermelink HK; Mason DY; Pileri SA
Haematologica; 2004 Aug; 89(8):957-64. PubMed ID: 15339679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]